Yahoo Web Search

Search results

1. • 

     Understanding Rosacea: 10 Natural Ways to Soothe and Calm Red, Irritated Skin

     Best Life· 6 days ago

     Rosacea is an inflammatory skin condition that can cause a range of uncomfortable symptoms. Many...

2. • Biodexa Pharmaceuticals (LON:MTPH) Share Price Passes Above 50 Day Moving Average of $18.00

     ETF DAILY NEWS· 1 day ago

     Biodexa Pharmaceuticals Plc (LON:MTPH – Get Free Report) shares passed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of GBX 18 ($0.23) and ...

3. • 

     Against Sunscreen Absolutism

     The Atlantic· 5 days ago

     The country’s predominantly white population has by far the world’s highest rate of skin cancer, and for years the public-health establishment has warned...

4. • vTv Therapeutics (NASDAQ:VTVT) Lowered to Sell at StockNews.com

     ETF DAILY NEWS· 1 day ago

     StockNews.com cut shares of vTv Therapeutics (NASDAQ:VTVT – Free Report) from a hold rating to a sell rating in a research report report published on Monday. vTv Therapeutics Trading Down 0.3 ...

5. • 

     Should You Avoid Infrared Saunas With Rosacea or Other Skin Conditions?

     PopSugar· 15 hours ago

     Infrared saunas are one of the hottest (no pun intended) trends in wellness and beauty right now....

6. • 

     Kids With Skin Diseases Face Stigma, Reduced Quality of Life

     Medscape· 2 days ago

     Most children with chronic skin diseases — such as acne, alopecia, eczema, psoriasis, and vitiligo —...

7. • Amgen Inc. (AMGN) To Go Ex-Dividend on May 16th

     ETF DAILY NEWS· 1 day ago

     Amgen Inc. (NASDAQ:AMGN – Get Free Report) announced a quarterly dividend on Wednesday, March 6th, RTT News reports. This represents a $9.00 annualized dividend and a dividend yield of 2.92% ...

8. • Q1 2024 Nektar Therapeutics Earnings Call

     Thomson Reuters StreetEvents via Yahoo Finance· 5 days ago

     Additionally, REZPEG was well-tolerated and treatment with REZPEG did not induce anti-drug antibodies in patients, which has been reported with some examples ...

9. • The hell of drug pricing boards

     Maryland Matters via Yahoo News· 6 days ago

     James K. Glassman, the well-known economist whose clients have included pharmaceutical companies, makes the case against prescription drug affordability boards. The post The ...

10. • 

      Nektar Therapeutics (NASDAQ:NKTR) Q1 2024 Earnings Call Transcript

      Insider Monkey via Yahoo Finance· 5 days ago

      Nektar Therapeutics (NASDAQ:NKTR) Q1 2024 Earnings Call Transcript May 9, 2024 Nektar Therapeutics...